Estrogen receptors (ER) mediate growth and differentiation in normal and neoplastic tissues. The presence of ER in breast cancers predicts for efficaceous therapy by estrogens or by antiestrogens, such as tamoxifen. The goal of this project is to elucidate mechanistic aspects whereby activated ER regulate gene expression. A short DNA segment found in estrogen regulated genes was able to confer estrogen responsiveness to another gene in transfection assays. We have synthesized a DNA segment with this sequence, 38 nucleotides long, and inserted it into a plasmid. The sequence bound partially purified calf ER with 400-fold greater efficiency than an equivalent length of plasmid DNA. Optimum binding occurred at 100-150 mM ionic strength, at pH 7.5-8.0, and plasmids with multiple sequence copies bound correspondingly more ER. We now plan to evaluate factors that regulate this binding and to correlate binding efficiency to capacity for induction of gene expression in vivo. We will explore the effects of ligand binding and transformation from the 4S to the 5S form on binding efficiency. We will examine the significance of ligand structure on binding efficiency by study of selected estrogens and an 4-OH tamoxifen, each known to evoke a different response in vivo. We intend to examine ER binding to plasmids containing 1, 2, 3, 4, etc., reiterated sequences, and from these results, infer the DNA length occupied by bound ER. The potential of ER for unwinding or helicase activity will be assessed; positive results will suggest a mechanism for ER action. The sequence contains an inverted repeat symmetry, asymmetrical regions and an A/T rich region. The importance of each region will be evaluated through use of synthetic sequence variants in the binding assay. Simultaneously, each sequence variant will be evaluated for its ability to induce increased gene expression in transfection assays (using ptk-CAT in MCF-7 cells). The correlation of these results will allow us to relate binding efficiency with transcriptional enhancement. Finally, we will ascertain whether communication between the ER-ERE complex and nearby promoters occurs by direct interactions (DNA looping model) or by conducting a signal down the DNA. Our approach will be to measure induction from two promoters placed downstream of an ERE. Also, the orientation of the ER site and promoter on the DNA helix will be altered by systematically changing the distance between them. This research should provide new insight into the characteristics of ER binding to DNA and its functional sequences.

Agency
National Institute of Health (NIH)
Institute
Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)
Type
Research Project (R01)
Project #
5R01HD024459-03
Application #
3325057
Study Section
Biochemical Endocrinology Study Section (BCE)
Project Start
1990-01-01
Project End
1992-12-31
Budget Start
1992-01-01
Budget End
1992-12-31
Support Year
3
Fiscal Year
1992
Total Cost
Indirect Cost
Name
University of Rochester
Department
Type
Schools of Dentistry
DUNS #
208469486
City
Rochester
State
NY
Country
United States
Zip Code
14627
Huang, Jing; Li, Xiaodong; Maguire, Casey A et al. (2005) Binding of estrogen receptor beta to estrogen response element in situ is independent of estradiol and impaired by its amino terminus. Mol Endocrinol 19:2696-712
Li, Xiaodong; Huang, Jing; Yi, Ping et al. (2004) Single-chain estrogen receptors (ERs) reveal that the ERalpha/beta heterodimer emulates functions of the ERalpha dimer in genomic estrogen signaling pathways. Mol Cell Biol 24:7681-94
Huang, Jing; Li, Xiaodong; Yi, Ping et al. (2004) Targeting estrogen responsive elements (EREs): design of potent transactivators for ERE-containing genes. Mol Cell Endocrinol 218:65-78
Yi, Ping; Driscoll, Mark D; Huang, Jing et al. (2002) The effects of estrogen-responsive element- and ligand-induced structural changes on the recruitment of cofactors and transcriptional responses by ER alpha and ER beta. Mol Endocrinol 16:674-93
Yi, Ping; Bhagat, Sumedha; Hilf, Russell et al. (2002) Differences in the abilities of estrogen receptors to integrate activation functions are critical for subtype-specific transcriptional responses. Mol Endocrinol 16:1810-27
Sathya, Ganesan; Yi, Ping; Bhagat, Sumedha et al. (2002) Structural regions of ERalpha critical for synergistic transcriptional responses contain co-factor interacting surfaces. Mol Cell Endocrinol 192:171-85
Muyan, M; Yi, P; Sathya, G et al. (2001) Fusion estrogen receptor proteins: toward the development of receptor-based agonists and antagonists. Mol Cell Endocrinol 182:249-63
Klinge, C M (1999) Estrogen receptor binding to estrogen response elements slows ligand dissociation and synergistically activates reporter gene expression. Mol Cell Endocrinol 150:99-111
Driscoll, M D; Sathya, G; Saidi, L F et al. (1999) An explanation for observed estrogen receptor binding to single-stranded estrogen-responsive element DNA. Mol Endocrinol 13:958-68
Klinge, C M; Studinski-Jones, A L; Kulakosky, P C et al. (1998) Comparison of tamoxifen ligands on estrogen receptor interaction with estrogen response elements. Mol Cell Endocrinol 143:79-90

Showing the most recent 10 out of 26 publications